Compare Stocks

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Regal Entertainment Group is an operator of theatre circuits in the United States. As of March 31, 2017, the Company operated 7,262 screens in 559 theatres in 43 states along with Guam, Saipan, American Samoa and the District of Columbia. The Company manages its business under theatre exhibition operations segment. The Company develops, acquires and operates multi-screen theatres primarily in mid-sized metropolitan markets and suburban growth areas of metropolitan markets throughout the United States. The Company operates multi-screen theatres. The Company is the parent company of Regal Entertainment Holdings, Inc. (REH), which is the parent company of Regal Cinemas Corporation (Regal Cinemas) and its subsidiaries. Regal Cinemas' subsidiaries include Regal Cinemas, Inc. (RCI) and its subsidiaries, which include Edwards Theatres, Inc. (Edwards), Regal CineMedia Corporation (RCM) and United Artists Theatre Company (United Artists).

Riverside Resources Inc. engages in the acquisition, exploration, and evaluation of assets in Canada, the United States, and Mexico. It primarily explores for gold, silver, rare earth elements (REE), and copper deposits. The company holds 100% interests in the Oakes Gold project covering an area of approximately 5,600 hectares; the Pichette comprises 1,650 hectares; and the Longrose and Vincent projects in located northwestern Ontario, Canada, as well as Duc project covering an area of approximately 600 hectares located in Ontario, Canada; and the Revel project includes 1,100 hectares located in the north of Revelstoke, British Columbia. It also holds 100% interests in the La Silla property, the Ariel property, the Teco project, the Cecilia property, the Australia project, the Suaqui Verde property, and the La Union property located in Mexico. In addition, the company has an option agreement to acquire 100% interests in the Elly-Anika and Chilco projects; the Deer Park and Sunrise projects located in British Columbia, Canada; and the Los Cuarentas property located in northern Sonora, Mexico. Riverside Resources Inc. was incorporated in 2006 and is headquartered in Vancouver, Canada.